Supplemental Information Deciphering ADME Genetic Data with an Automated Haplotype Approach Yingying Guo1*#, Mark W. Farmen2*, Yan Jin3, Hsiu-Yung C. Lee2, Michelle A. Penny4, Kathleen M. Hillgren1, Stewart L. Fossceco2 1Drug Disposition, 2Discovery and Development Statistics, 3Clinical Pharmacology, and 4Tailored Therapeutics, Eli Lilly and Company, Indianapolis, IN * Drs. Guo and Farmen have made equivalent contributions to this publication. # Address for correspondence: Yingying Guo, PhD, Drug Disposition of Eli Lilly and Company, Lilly Corporate Center DC 0714, Indianapolis, IN, 46285, USA Telephone: (317) 277-4324 Fax: (317) 655-1184 E-mail: guoying@lilly.com SUPPLEMENTAL INFORMATION Includes: Supplemental Materials and Methods (page 2-4) Supplemental Tables S1 – S12 (page 5-19), S13-15 (page 20-24) SAS Programs used for Analyses (page 20-91) Supplemental Materials and Methods Allele-specific Sequencing Long-fragment PCR cloning of desired fragments from each individual chromosome was performed on samples that harbored alleles of interest as determined by the DMET Assay. Allele-specific sequencing of each individual clone was then performed in order to confirm the linkage of all the markers of interest. The experimental procedures are detailed below. Long-range PCR was conducted in a final volume of 50 µL, containing 200-400 ng human genomic DNA, 400 µM of each deoxynucleotide triphosphate, 200 nM of each primer, 7% DMSO, 1M of Betaine, and 2.5 U of Takara LA Taq Polymerase (Takara Mirus Bio). Amplification consisted of an initial denaturation step at 94C for 1 min, followed by 14 amplification cycles (94C for 30 seconds, 57C for 30 seconds and 68C for 9 min) and an additional 16 amplification cycles (94C for 30 seconds, 57C for 30 seconds and 68C for 9 min + 15 seconds/cycle), and a final incubation at 72C for 10 min. All of the forward and reverse primers information is included in Supplemental Table 5. These products were purified and cloned into a TOPO XL PCR cloning vector using the TOPO XL PCR Cloning kit (Invitrogen) per the manufacturer’s instructions. For each sample, twelve clones from each plate were picked and cultured in a 96-well format. Diluted cultures were transferred to a denaturing buffer that was part of the TempliPhi DNA Sequencing Template Amplification kit (GE HealthCare/Amersham Biosciences). This buffer causes the release of plasmid DNA but not bacterial DNA. Cultures were heated, cooled, spun, and transferred to fresh plates containing the TempliPhi enzyme and other components. This mixture was incubated at 30C for 18 hours to promote amplification of the plasmid templates. These products were then spun and heated to 65C to destroy the enzyme. Plasmid templates were then bidirectionally sequenced using the Big Dye, version 3.1 sequencing kit (Applied Biosystems). For each reaction, an appropriate sequencing primer was used that was designed to anneal to a unique location of the template (data on file). Cycle sequencing was carried out with an annealing temperature of 50C, an elongation temperature of 60C, and a denaturation temperature of 96C, for a total of 30 cycles. Sequencing reaction products were run on an ABI 3730XL DNA sequencer with a 50 cm capillary array using standard run mode. All bidirectional sequence data were analyzed using Agent, a proprietary sequencing analysis program (Celera). DNA Sequencing A "boost/nest" PCR method was used to prepare templates for the DNA sequencing reactions. In this method, a boost reaction with a larger fragment was first carried out, and that product was then used as a template for the nest reaction, using TempliPhi DNA Sequencing Template Amplification kit (GE HealthCare/Amersham Biosciences) per manufacture’s instructions. All of the forward and reverse primers information is listed in Supplemental Table 12. Amplification consisted of an initial denaturation step at 94 degree for 4 min, followed by 26 amplification cycles (94C for 20 seconds, 55C for 25 seconds and 72C for 1 min), and a final incubation at 72C for 7 min. The nest product was bidirectionally sequenced using Sanger sequencing. All bidirectional sequence data were analyzed using the proprietary sequencing analysis program Agent (Celera).